Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Income from Continuing Operations of 13382000.0 for Q1 2026, up 35.38% year-over-year from 9884486.05 in Q1 2025, and down 411.74% quarter-over-quarter from 2615000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 13382000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 35.38% year-over-year to 13382000.0; the TTM figure through Mar 2026 stood at 43736000.0 (up 50.92% YoY), while the FY2025 annual figure was 51064000.0, up 39.64% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 13382000.0, down from 2615000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 2615000.0 in Q4 2025, with the low at 37106000.0 in Q2 2022.
- The 5-year median for Income from Continuing Operations is 16682000.0 (2024), against an average of 17809000.0.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations plunged 597.22% in 2022, then soared 92.43% in 2025.
- Establishment Labs Holdings' Income from Continuing Operations stood at 13562000.0 in 2022, then sank by 51.47% to 20542000.0 in 2023, then slumped by 68.1% to 34531000.0 in 2024, then jumped by 92.43% to 2615000.0 in 2025, then plunged by 411.74% to 13382000.0 in 2026.
- Business Quant data shows ESTA's Income from Continuing Operations at 13382000.0 in Q1 2026, 2615000.0 in Q4 2025, and 11146000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Establishment Labs Holdings | 2.20 Bn | 2.13 Bn | 47.71 Mn | -11.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.75 Mn |
| Mar 31, 2026 | -13.38 Mn |
| Dec 31, 2025 | -2.62 Mn |
| Sep 30, 2025 | -11.15 Mn |
| Jun 30, 2025 | -16.59 Mn |
| Mar 31, 2025 | -20.71 Mn |
| Dec 31, 2024 | -34.53 Mn |
| Sep 30, 2024 | -16.68 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -16.20 Mn |
| Dec 31, 2023 | -20.54 Mn |
| Sep 30, 2023 | -29.27 Mn |
| Jun 30, 2023 | -16.75 Mn |
| Mar 31, 2023 | -11.94 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -18.61 Mn |
| Jun 30, 2022 | -37.11 Mn |
| Mar 31, 2022 | -5.93 Mn |
| Dec 31, 2021 | -14.19 Mn |
| Sep 30, 2021 | -14.68 Mn |